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uterine

fibroids
used to mean giving
up a lot more than
a night in the hospital
hile uterine fibroid rumors are benign, their impact on a
woman's life is anything but—often resulting in a hysterectomy or other invasive surgeries. But today, many women
are choosing procedures that spare the uterus.
Uterine Fibroid Embolization (UFE) is a minimally invasive
procedure performed by an interventional radiologist. By blocking the
blood flow to the tumors and causing them to shrink, the procedure is
approximately 90% successful at alleviating the heavy bleeding and painful
periods often associated with fibroids.
As compared with other fibroid treatments, UFE
usually requires only an overnight stay in the hospital
and has a quicker recovery time.
Established in 1998, the Washington University
Comprehensive Fibroid Center has accumulated the
largest experience with UFE treatment in St. Louis. Most
major insurance carriers, Medicare, and Medicaid recognize UFE as an accepted alternative treatment for fibroids.
For more information about UFE or other minimally
invasive interventional radiology procedures offered
at Washington University Medical Center,

call (314) 362-2353.
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AN INTERVIEW WITH SIMON POWELL, MD, PHD

Simon Powell, an internationally known cancer
physician-scientist, was named chairman of the
Department of Radiation Oncology in July 2004.
Now, nearly a year later, he discusses the challenges
of leading the four-year-old department and outlines
his goals for patient care, research, and education.

IF THE SHOE DOESN'T FIT.

Many of the 18 million Americans with diabetes
suffer from foot problems, including a condition
in which severely diminished sensation in the
feet causes ulcers and can lead to amputation.
Researchers from the Institute's Electronic
Radiology Laboratory and from the School of
Medicine's Program of Physical Therapy are using
spiral CT to develop a three-dimensional model
that they hope will revolutionize orthotic design.

OSTEOPOROSIS: THE BRITTLE BONE DISEASE

At around 30 years of age, men and women slowly
begin to lose bone mass. And in the five years
following the onset of menopause, bone density
in women deteriorates rapidly. Nuclear medicine
physicians at Mallinckrodt Institute are using
Dual-Energy X-ray Absorptiometry to diagnose
bone loss, enabling patients to begin treatment
that will fight the advance of osteoporosis.

ON THE COVER According to the National Institutes of Health, osteoporosis is a health threat for 44 million Ameri-

Visit the MIR web site at
w.mir.wustl.edu

cans, 68% of whom are women. It is estimated that one out of two women over the age of 50 will have an osteoporosis-related fracture in her lifetime. The disease can develop at any stage in a person's life, but osteoporosis can
be prevented and treated. Illustration by Matt Kindt.
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They are all
winners...
Since 1989 the radiation
oncology residents annually
select the Teacher of the
Year recipient by nominating
and voting for the faculty
member who makes a significant contribution to radiation
oncology resident education
during the academic year.
The award is presented each
year in December.
This year the residents
broke from tradition. "The
residents did not select a
teacher of the year for 2004,"
says Parag Parikh, MD,
radiation oncology assistant
chief resident. "Many of the
attendings [physicians on
faculty] this year went
above and beyond in their
teaching responsibilities,
from increased participation
in the Patient Management
Conference to their support
of our new Management and
Techniques sessions. We
[the residents] did not think
it was fair—nor could we
come to a conclusion—to
name one attending as the
'Teacher of the Year.'"

Past award recipients
• Susan Shapiro, MD—1989
• Carlos Perez, MD—1990,
2003
• Perry Grigsby, MD,
MBA—1991, 1995, 2000
• JeffMichalski, MD—1992
• Russell Gerber, MS—1993
• Mary Graham, MD—1994
• James Purdy, PhD—1996
• Marie Taylor, MD—1997
• David Gius, MD, PhD—
1998
• Jeffrey Bradley, MD—
1999
• Joseph Simpson, MD,
PhD—2001
• Imran Zoberi, MD—2002

37th Wilson
Award
presented
Yasha Kadkhodayan, a
fourth-year medical student,
received the 2004-2005
Hugh M. Wilson Award for
Meritorious Work in Radiology. The award is presented
in honor of Mallinckrodt
Institute's second director,
who was an advocate of the
advancement of education.
Kadkhodayan earned
an undergraduate degree,
majoring in bioengineering,
from the University of Illinois
at Chicago (UIC). During his
four years at UIC, Kadkhodayan participated in research
projects involving the use of
phase-contrast magnetic resonance imaging (MRI) to study
the craniospinal system.

During his first year at
Washington University in
St. Louis School of Medicine
(WUSM), Kadkhodayan
voiced his interest in neuroradiology and radiology to
Colin Derdeyn, MD, associate professor of radiology
and of neurology and neurological surgery. With
Derdeyn's sponsorship,
Kadkhodayan received
an American Academy of
Neurology summer research
fellowship and worked
closely with doctors
Derdeyn, Christopher
Moran, and DeWitte Cross—
all members of the Institute's
interventional neuroradiology service.
Kadkhodayan worked
on several projects, including MRI measurements of
brain temperature in stroke,
and performed an exhaustive
chart review study. His
efforts resulted in a paper on
"Yield of conventional
angiography for primary
angiitis of the central
nervous system" being published in Radiology and a
second paper—"Procedural
complications of a carotid
angioplasty and stenting
without cerebral protection
devices"—published in
Neurosurgical Focus. Two
additional papers have been
accepted for publication by
the American Journal of
Neuroradiology.
Kadkhodayan will begin
his first year of diagnostic
radiology residency at
Mallinckrodt Institute in
July 2006, after completing a
preliminary training year in
medicine at Barnes-Jewish
Hospital.

WUSM ranks
third in nation
According to the April
2005 U.S. News & World
Report survey, Washington
University in St. Louis
School of Medicine (WUSM)
ranked third in the nation
among research intensive
medical schools. Among the
top 10 schools, Harvard University took first-place honors and Johns Hopkins
University placed second;
following WUSM were the
University of Pennsylvania,
University of California-San
Francisco, Duke University,
University of Washington,
Stanford University, University of Michigan, and Columbia University.
U.S. News & World
Report initiated the professional and graduate school
rankings in 1987. WUSM
annually has placed in the
top 10 schools and, since
1998, has ranked first in
student selectivity. For the
eighth consecutive year,
WUSM's students have had
the highest undergraduate
grade-point averages and
the highest scores on
medical school entrance
examinations.
Listings for all Washington University in St. Louis
schools, departments, and
programs are available at
news-info.wustl.edu/rankings.

MALLINCKRODT INSTITUTE OF RADIOLOGY

Miller elected
ABNM
chairman
Tom Miller, MD, PhD,
professor of radiology and
of biomedical engineering,
has been elected to a oneyear term as chairman of the
American Board of Nuclear
Medicine (ABNM). Founded
in 1971, the ABNM was
established to set education
standards and to evaluate
the competence of physicians providing nuclear
medicine services in the
United States. ABNM's
responsibilities include setting the requirements for
certification, conducting
examinations leading to
certification in nuclear
medicine, and issuing
certificates to those
physicians who fulfill the
requirements. From 1972
to 2004, the ABNM has
certified 4,869 physicians.
The 12 Board members
serve three-year terms;
officers, a one-year term.
Henry Royal, MD,
professor of radiology, is
the ABNM executive director, and Barry Siegel, MD,
professor of radiology and
of medicine, is designated as
a life member of the Board.
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Matching
Program
results
announced
On July 1, 18 physicians
will begin their first year of
training in diagnostic radiology. These promising
trainees come to MIR from
excellent medical schools:
• Weill Medical College
of Cornell University
• Duke University School
of Medicine
• Emory University
School of Medicine
• Georgetown University
School of Medicine
• I.M. Sechenov Moscow
Medical Academy
• Indiana University
School of Medicine
• Johns Hopkins University
School of Medicine
• Tulane University
School of Medicine
• David Geffen School of
Medicine at the University
of California, Los Angeles
• University of MissouriColumbia School of
Medicine
• University of Pennsylvania
School of Medicine
• Washington University
in St. Louis School of
Medicine.

David Johnson, MD, ASCO president, presented the award to Farria (left)
and Darlene Bird, clinical research coordinator, at the 2005 ASCO Annual
Meeting in Orlando, Florida.

Farria receives
clinical trials
award
On behalf of the Breast
Imaging Team at Siteman
Cancer Center (SCC), Dione
Farria, MD, received the
Clinical Trials Participation
Award from The American
Society of Clinical Oncology
(ASCO), one of the world's
leading organizations representing physicians who treat
cancer. The award was
created in 2003 to publicly
honor practices and institutions that actively participate
in clinical trials research.
The award program is
supported by a grant from
the Coalition for National
Cancer Cooperative Groups.
Farria and Katherine
Jahnige Matthews, MD,
assistant professor of obstetrics and gynecology, are
directors of the SCC Program for the Elimination of
Cancer Disparities (PECaD).

The SCC program works
within existing community
networks to build trusting
relationships that ultimately
help to attract patients to
clinical trials. PECaD also
provides the St. Louis-area
community with health
information and assistance
in obtaining patient care. As
the largest of the multidisciplinary clinical centers in the
Center for Advanced Medicine, the SCC is a collaborative effort of Washington
University in St. Louis
School of Medicine and
Barnes-Jewish Hospital.
As principal investigator, Farria received a Community Networks Program
grant of $1.2 million from the
National Cancer Institute to
support the PECaD work.
Matthews is coinvestigator
for the five-year grant.

SPOT NEWS
MIR
researchers
participate
in nanotechnology grant
In a 2005 report on the
nation's nanotechnology
research efforts, the President's Council of Advisors
on Science and Technology
determined that the United
States is the acknowledged
international leader in nanotechnology research and
development and recom-

mended that further steps be
taken to facilitate technology
transfer from the laboratory
to the marketplace. The
Council also called for
continued research on
environmental, health, and
other societal issues and for
support for education and
workforce preparation.
Nanotechnology—
working with matter that
is one billionth of a meter—
has been hailed as the "new
industrial revolution."
Researchers across the
nation are attempting to
devise methods for imaging
and constructing at the

atomic and molecular level.
As part of a new nanotechnology initiative, The
National Heart, Lung, and
Blood Institute (NHLBI) of
the National Institutes of
Health selected Washington
University in St. Louis
(WUSTL)asoneoffour
universities designated as a
Program of Excellence in
Nanotechnology (PEN). The
WUSTL program will serve
as the administrative center
for the national project.
The NHLBI awarded a
five-year, $12.5 million grant
to Principal Investigator
Karen Wooley, PhD, profes-

CCIR progress
The first step in the construction of the Center for Clinical Imaging Research (CCIR) was to completely gut the 9,000 square-

sor of chemistry, and
Co-principal Investigator
Michael Welch, PhD, professor of radiology, of chemistry, and of molecular
biology and pharmacology,
to focus on the "development of nanoscale agents
that can be assembled,
labeled, targeted, filled,
and activated for eventual
diagnosis and treatment of
various diseases relevant to
NHLBI." Welch's expertise
in the area of rapid synthesis
of positron-labeled organic
chemicals—a vital component in the development of
positron emission tomography at the Institute in the
1970s—and his research
on developing image
enhancements ultimately
used in clinical radiology
techniques and procedures
will play an important role
in the PEN project.
Among the 13 WUSTL
and School of Medicine PEN
collaborators are Mallinckrodt Institute's Robert
Gropler, MD, professor of
radiology, of medicine, and
of biomedical engineering;
Pamela Woodard, MD,
assistant professor of radiology; Daniel Schuster, MD,
professor of medicine and
of radiology. Also involved
are Carolyn Anderson, PhD,
associate professor of radiology; Robert Mach, PhD,
professor of radiology; and
Jason Lewis, PhD, assistant
professor of radiology.
More information on
the PEN project is available
on the Internet: NHLBI
(www.nhlbi.nih.gov) or the
National Nanotechnology
Initiative (www.nano.gov/).

foot area on 10 West Pavilion. The CCIR is part of the Institute's strategy for providing advanced imaging resources and
support for clinical investigators whose biomedical research will facilitate better diagnosis and management of disease. Mark
Mintun, MD, professor of radiology, is the CCIR director.
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An Interview
with Simon Powell, MD, PhD
In July 2001, Washington
University School of Medicine (WUSM)
established the Department of Radiation
Oncology from what had been known
as Mallinckrodt Institute's Division of
Radiation Oncology. Carlos Perez, MD,
was appointed interim chairman of the
new department. After an extensive
national search by WUSM, Simon Powell,
MD, PhD, was named professor and
department chairman in July 2004.
Here, Dr. Powell discusses
the challenges and goals for the
department, particularly in the areas
of technology, patient care, research,

Focal Spot (FS): You came to
Washington University Medical
Center from one of the United
States' healthcare giants—Harvard
University and Massachusetts
General Hospital. What were your
first impressions of Washington
University Medical Center?
Dr. Powell (SP): I was impressed
by the size and range of activities
in the Medical Center. My first and
continuing impressions are that
there are no limits to what can be
achieved on this site.
FS: The Department of Radiation
Oncology encompasses patient
care, research, and teaching. What
are the department's strengths in
handling such a wide range of
responsibilities?
SP: Excellent faculty. They
drive everything. The faculty I
inherited was already in good
shape, although I am devoting a
significant amount of time to new
faculty recruitment.

and education.

FS: The radiation oncology
residency training program is
well-known nationally. How
important do you think the
department's mentoring program,
research facilities, and affiliations
with BJC HealthCare are in
attracting residents to the training
program?
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An Interview

SP: I think prospective residents
are looking for a well-balanced
program. Good clinical experience,
opportunities for research, and
excellence in mentoring. The operation of our department's program in
a large general medical center
provides a realistic balance of the
role of radiation oncology in the
context of other medical specialties.
FS: Whether it can be attributed to
the Internet, the media, or just to
curiosity, patients are better
informed regarding healthcare
options. They expect to be actively
involved in the health-related decision-making process and are proactive in seeking cancer care. How is
this physician-patient partnership
addressed in the department?
SP: We spend a lot of time with our
patients at their first consultation.
We gather as much essential information as possible prior to seeing
the patient, so we can focus our time
on answering their questions. Since
radiation oncology often comes later
in the medical process, our consultations provide an opportunity for
patients to get a deeper perspective
of their treatment options.
FS: What effect do you think rising
technology costs and reduced
Medicare and managed care
reimbursements are having on
cancer care?

r
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SP: They clearly have an impact, but
both are changing. New technology
often starts with one level of CPT
[Current Procedural Technology]
code payment but, in time, the CMSbased [Centers for Medicare and
Medicaid Services-based] Medicare
payments tend to go down. What we
must avoid is that payment policies
start to dictate practice.

lilt ulty.

FS: In 1971, the United States government hailed the National Cancer
Act as a "national battle plan to
eradicate cancer in our lifetime."
Nationally, what advancements do
you think are bringing us closer to
that cure?
SP: The major area of development
is the recognition that site-specific
cancers are a mixture of diseases,
with different characteristics.
These characteristics of the tumors
can tell us how to treat individual
tumors optimally. This will
increasingly become a combination
of a biological agent with a conventional cytotoxic agent, such as
radiation and chemotherapy.
FS: In the past decade, there has
been tremendous technological
growth in radiation therapy, especially in computer-based systems.
What advances do you foresee in the
next decade? What role will WUSM
radiation oncology play in the
development of new technology?
SP: The last decade was characterized by the development of what is
called "intensity modulated" radiation therapy. This allowed the
delivery of radiation to all types of
complicated tumor shapes. The
next decade will be characterized
by the introduction of image guidance. This new technology allows
greater precision in the delivery of
treatment and can allow what is
called "adaptive therapy." Adaptive
therapy takes into account the
changes in the size and shape of
the tumor during the course of
treatment. By acquiring two new
treatment machines that offer
full-image guidance, WUSM hopes
to play a key role in developing
the new applications of imageguidance therapy.

//
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FS: The department has a broadbased research program. Do you
have plans for research expansion?
SPlYes. We plan to expand our
research mission in all divisions of
the department. I have created a new
Division of Bioinformatics and
Outcomes Research. Computerbased data analysis is becoming
increasingly important in oncology
research. The biggest change will be
in our biology division, where we are
developing a program in DNA repair
and genome stability for the Siteman
Cancer Center.
FS: What effect will the increased
competition for research dollars
have on the department's research
programs?
SP: The competition will apply
more pressure on our faculty—
and every research group in the
country—to develop competitive
research programs. We will have
to focus our research on areas of
clear strength and work on our
grant submissions to make them
as effective as possible.
FS: How important is interdisciplinary collaboration to the
advancement of science and
medicine? Does radiation oncology
have interdisciplinary programs
in place? Future
plans?

there are no limits..."
SP: The DNA repair program will
be interdisciplinary, like all Siteman
Cancer Center programs. We also
plan an interdivisional group under
the umbrella of the Center for
Molecular Targeted Radiotherapy.
This center will integrate biology,
physics, and clinical work with a
strong translational initiative. We
also see the interdisciplinary disease
focus groups having a much stronger
presence in the years to come.
FS: The current focus at most medical centers is on cost control. How
can the department continue to drive
progress while reducing cost?
SP: We have just completed a thorough review of our faculty and staff
positions. We cannot afford to keep
positions that are no longer needed in

the new formula for the department.
Although it is never a favorite job to
eliminate positions, we think the
department will emerge stronger as
a consequence. It will allow new
initiatives at a time of being costconscious.
FS: What are your overall longrange goals for the Department
of Radiation Oncology?

SP: Our long-range goals are to
develop intradepartmental translational programs arising out of strong
basic science research. In academic
medicine, the goal is always to push
the envelope of treatment. In concert
with strong Siteman Cancer Center
programs, this new vision for our
department can flourish.
FS: Short-range goals?
SP: The short-range goals
are to complete our new
faculty recruitments
successfully. As I stated
earlier, faculty is the key
to our strength in our academic mission. We have
reorganized our administration to allow greater
efficiency in supporting
our new initiatives.
FS: Anything you would
like to add?
SP:Yes. My first seven
months have been very
busy but very productive.
All of the faculty and staff
I have met have been
extraordinarily supportive
in helping this new
department on the road to
becoming the finest radiation oncology department
in the country.
FS: Thank you, Doctor
Powell. EH
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Fit

A typically pleasant St. Louis spring
beckons walkers, joggers, golfers,
skaters, and bikers to the outdoors.
But for millions of people with diabetes
and peripheral neuropathy, a simple stroll
poses a hidden threat to future mobility.

Many of the 18 million Americans
with diabetes suffer from severe foot
problems, including neuropathy, bone
and joint deformities, and ulcers.
Diabetes damages the communication
network from the brain and spinal cord to
the extremities—a condition called diabetic
peripheral neuropathy (DPN). Patients with
DPN lose sensation in their feet, and any
minor cut or blister can lead to a serious foot
ulcer. DPN also causes weakness in certain
muscles of the foot; the anatomy of the foot
actually changes as people unknowingly
adapt their gait to compensate for the loss
of muscle. Pressure builds on the metatarsal
heads (the joints under the ball of the foot),
causing internal or external ulcers.

FOCAL SPOT, SPRING 2005

Successful treatment and
prevention of foot ulcers
requires specially fitted shoes
and orthotic devices, such as a
special shoe insert, that redistribute pressure away from
parts of the foot that are ulcerated or may develop ulcers.
However, even with orthotic
devices, ulcers recur in more
than 50 percent of cases.
Unless they diligently examine
their feet for subtle changes in
skin appearance, patients may
not realize that an orthotic
device is not functioning
properly until an ulcer reappears. A severely infected foot
may have to be amputated.
More than 80,000 lower-limb
amputations are performed on
diabetic patients in the United
States every year, at a cost
of $30,000 to $60,000 per
operation. According to the
American Diabetes Association, up to 85 percent of these
amputations could be prevented with better diagnosis
and treatment.
Mallinckrodt Institute of
Radiology (MIR) scientists are
collaborating with a team of
researchers and technicians,
looking at new ways to assess
severe foot problems in diabetic
patients and to provide the best
orthotic device for any patient as
quickly as possible. Kirk Smith,
an MIR senior research engineer,
explains, "We are using spiral CT
[computed tomography] technology to portray the structure of a
diabetic patient's foot in a way
that has not been done before.
Our goal is to help clinicians
match the best orthotic device
with a patient's unique foot
structure and prevent the all-toocommon recurrence of ulcers."

Kirk Smith

A remarkable interdisciplinary
collaboration has advanced
research into the causes and treatment of a diabetic patient's foot
problems from the discovery phase
to potential practical application.
The latest in a series of research
studies by the team will be published soon in the Journal of
Biomedical Engineering. The
paper will describe a working
three-dimensional model of foot
problems caused by diabetes. The
team hopes the research will revo-

Shoe Doesn't Fit

lutionize orthotic design—a field in
which methods have changed little
in the 30 years since the advent of
modern orthotics.
Michael Mueller, associate
professor of physical therapy,
emphasizes the advantages of the
interdisciplinary research: "This
team has the expertise to evaluate
all the complex variables that can
affect the development of foot
problems in the diabetic patient,
such as the physiological structure
of the foot, the effect of gait on
pressure points, and the material
properties of the orthotic devices.
And we are using advanced computational modeling techniques to
test the reliability of our predictions. Orthotic design today is
more art than science, and good
design is largely a function of the
experience of the pedorthist. We're
trying to bring science into the picture to improve orthotic design."
This is not the first collaboration between physical therapy
clinicians and MIR researchers.
Michael Mueller, PhD

THE RESEARCH TEAM
Washington University
Department of Radiology
(Mallinckrodt Institute}

• Kyongtae Bae, MD, PhD, associate professor of radiology
• James Blaine, DSc, emeritus professor of radiology
• Paul Commean, BEE, senior
research engineer
• Tom Pilgram, PhD, instructor in
radiology
• Fred Prior, PhD, research associate professor of radiology
• Kirk Smith, AAS, senior research
engineer

10

Program in Physical Therapy

• Mary Hastings, DPT, instructor in
physical therapy
• Joseph Klaesner, PhD, research
assistant professor of physical
therapy
• Donovan Lott, MS, PT, predoctoral trainee
• Michael Mueller, PhD , associate
professor of physical therapy
• Dequan Zou, DSc, research assistant professor of physical therapy
Department of Orthopaedic Surgery

In the late 1990s, Smith and a
research team developed betterfitting prosthetic devices for
patients who had an amputated
limb. As CT technology advanced,
and lower-dose scans became the
norm, Mueller asked Smith if spiral
CT could be used to develop a
better understanding of the
underlying causes of foot problems
caused by diabetes. The team
embarked on a series of studies
that would give a complete picture
of foot structure and peak plantar
pressures, the measure of pressure
on the foot that eventually causes
ulcers to form.
Before CT, evaluating the
structure of the foot was like
putting together a jigsaw puzzle—
with only half the pieces. X rays
could display bones but only in a
single plane. Viewed in profile, only
the first or fifth metatarsal could be
examined in detail, as the interior
views were obscured. Ultrasonography lent information about soft
tissue but not in connection with
bone detail. Research involving

Department of Mechanical Engineering
and Aerospace

• Ricardo Actis, DSc, adjunct p
fessor of mechanical engineer
• Barna Szabo, PhD, professor
of mechanical engineering and
aerospace
Other collaborators

• Liliana Ventura, Engineering Software Research & Development,
Inc.
• pedorthist consultants

• Jeffrey Johnson, MD, associate
professor of orthopaedic surgery
Matthew Silva, MD, associate professor of orthopaedic surgery
MALLINCKRODT INSTITUTE OF RADIOLOGY

MIR scientists and Mueller has
demonstrated spiral CT's many
advantages over these earlier
methods. With CT, bone structure
and soft tissue can be evaluated
together and can use the same
scale, and three-dimensional views
allow greater detail examination.
The team was able to take accurate
measurements of such key attributes as toe angle for each
metatarsal, severity of "hammer
toe" deformity, bone density, and
hallux valgus angle.
The team also used CT to
understand how soft tissue is
affected by pressure from standing
and walking. Using a specially
designed seat, a plate to provide
pressure, and special sensors
taped to a person's foot, the team
simulated standing, push-off, and
walking pressures on the foot. By
recording soft tissue thickness,
peak plantar pressure, and contact
area between foot and plate,
Smith and his colleagues were
able to complete the puzzle of the
foot problems caused by diabetes

II

I

and to understand the major risk
factors potentially leading to
amputation.
Now, with the assistance of
Barna Szabo, professor of mechanical engineering and aerospace, the
research team is building a threedimensional model of a foot with
the typical features of a person
suffering from DPN. "Our goal,"
explains Smith, "is to predict the
characteristics of the orthotic
device so that the first fit is the
best fit. If we are successful, the
recurrence rate of ulcers in a
patient's foot will drop, new ulcers
will not form, and patients will
be spared amputation."
Three-dimensional modeling
uses data collected through spiral
CT from actual patients and a
complex theoretical mathematics
technique called finite element
analysis, which was originally used
in the aerospace industry and now
CT Loading Device. A pressure sensor is attached to the
study volunteer's foot, which is placed flat against a
force plate.

Some patients with foot ulcers wear specially
fitted shoes equipped with an insert that
alleviates pressure on the affected area.

STATISTICS
• 18.2 million (6.3%)
Americans have diabetes.
• 60% to 70% of people with
diabetes have mild to severe
forms of nervous system
damage, including impaired
sensation in the feet.
• Severe forms of diabetic
nerve disease are a major
contributing cause of lowerextremity amputations.
• 1 in 4 people with diabetes
will develop a foot ulcer in
their lifetime.

E23

• In the St. Louis metro area,
5.4% of the population has
diabetes.
• In a 2003 survey of diabetic
patients in the St. Louis-area,
14% reported having sores or
irritations on their feet that
took more than four weeks
to heal.
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Sources: State of Missouri
Department of Health and Senior
Services (www.dhss.mo.gov);
American Diabetes Association
(www.diabetes.org)

ll

Shoe Doesn't Fit

is applied in every engineering field
from industrial design to biomedical engineering. Working with CT
images and data collected by MIR
researchers, Szabo's team constructed a model of the bones,
cartilage, tissue, and tendons of a
diabetic patient's foot. Using finite
element analysis the team solved
a system of nonlinear equations
representing the deformation of
the foot under load. The procedure
requires the construction of a mesh
of tetrahedral shapes (elements)
describing the topology of each
object. A tetrahedral is a polyhedron composed of four triangular
faces; one of the MIR models used
78,112 tetrahedrons to create the
3-D foot model.
Smith and the team are still
refining this complex model. Once
tested and validated, it could use
patient-specific data to reflect that
patient's bone structure and tissue
properties. Initially Smith expects
to obtain these details via CT scan
but eventually hopes to employ a
less expensive method such as
X ray. Combined with the patient's
weight, the model then could "try
on" different orthotics and take a
virtual walk. Simulating pressure
from standing, pushing off, and
walking, the model will show
whether the device distributes
pressure away from areas at risk
for ulceration. By adjusting the

type or thickness of the virtual
orthotic's material, or its placement
or shape, researchers can find the
best orthotic design quickly and
with minimal modification. One
day, if all of the pieces come
together, treating foot problems
caused by diabetes will be just a
walk in the park. E333

3D image of foot and angled tendon.
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Density
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/THE BRITTLE BONE DISEASE

t's no accident that people around
the world tend to be preoccupied with
bones. Among the most devastating effects
of the postmenopausal retreat of estrogen is
the loss of bone density. "Peak bone mass occurs
at about age thirty. Bone mass falls off slowly, but in
the five years after menopause women lose bone mass
more rapidly," says Keith Fischer, MD, an associate
professor of radiology and a nuclear medicine physician at Mallinckrodt Institute of Radiology (MIR). He

TOi0
is not an inevitable part #aging: it is preventable. So it is vital that all of
us, of all ages, starHaking care of our bones now, before it is too late."
- THE DUCHESS OF CORNWALL, PRESIDENT OF
GREAT BRITIAN'S NATIONAL OSTEOPOROSIS SOCIETY

uses Dual-Energy
X-ray Absorptiometry
to diagnose bone loss
in his patients. DEXA,
as it is sometimes

called, is the established standard for measuring bone
mineral density and tracking bone loss. It is used most
commonly to diagnose osteoporosis, a condition in
which a gradual loss of calcium causes the bones to
become thinner, more fragile, and more likely to break.
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"Ideally, a baseline bone
density study is performed on
a woman when she is perimenopausal and first starts
to experience menopausal symptoms. That way, if she is already
osteopenic, her physician can
initiate treatment," says Fischer.
Osteopenia is a mid-point
value of bone density, between
the normal range and the range
designated as osteoporosis.
Fischer says that men also can
develop osteoporosis, but they
seem to lag behind women by
10 years. Men over 70, especially
!
if
they have a high risk of
fractures, should have bone
density testing.
How DEXA Works
According to Fischer, DEXA
measures the amount of calcium
phosphate absorbing X rays.
Bone mineral loss accelerates
after menopause and affects the
trabecular bone that forms the
body's internal supports. The
vertebrae are made up of 75%
trabecular bone and the hips are

50%, so the spine should be the
more sensitive structure for
first detecting osteoporosis.
However, in the older
patient, other factors
complicate the results.
There are calcium
deposits in plaque in
the aorta that runs
through the same
area and in the facet
joints between the
vertebrae where
osteoarthritis
is more pronounced. This
calcium can be
measured as bone
mineral, thus falsely
elevating the measured
bone mineral density.

Figure A (below): A healthy bone
includes protein, calcium, blood
vessels, and bone marrow that fill
in the interior spaces.
Figure B (below): An osteoporotic bone
has large "holes," making it fragile and
more likely to break.

Keith Fischer, MD

FOCAL SPOT, SPRING 2005

IT)

ITTLE BONE DISEASE

V

i

DEXA scans of an osteoporotic bone (top)
and a healthy bone (bottom).
HOBGC

The DEXA scanner (below).

"DEXA doesn't differentiate
between sources of calcium. It
counts them all. That's why we
also study the hip because it
doesn't have those confounding
characteristics," says Fischer.
"The patient is defined as being
osteoporotic if either of those
measurements is more than two
point five standard deviations, or
SD, below the peak normal bone
mineral density."
DEXA works by focusing an
X-ray beam on the bone and
measuring how much of the beam
penetrates the bone. More mineral present in the bone equates
to less penetration of the X-ray
beam. Different scores have been
developed to describe various
levels of bone loss by comparing
them to established standards.
Two scores are calculated and
communicated in a report to the
referring physician. The "Zscore" is a number representing the amount of
bone the patient has,
as compared to other
people of like age
and sex. The
"T-score" compares the amount
of bone the
person has, as
compared to a
young adult of

the same sex at peak bone mass.
If either the hip or the spine
has a T-score of 2.5 SD below
peak bone mass, the diagnosis
is osteoporosis.
"However, even before a
patient develops osteoporosis,
they have lost some bone mass,"
says Fischer. According to
Fischer, patients whose readings are 1.0 to 2.5 SD below
peak are designated as having
osteopenia, or low bone
density. If a patient already
is osteopenic, therapy may
be appropriate to head off
osteoporosis.
Low DEXA scores indicate
the need for treatment to prevent fractures and subsequent
disability. "At Mallinckrodt
Institute, we are interested in
the central structures such as
the spine and hips—bones
that suffer the ravages of
osteoporosis. There are three
hundred thousand hip fractures
a year in the United States and
even more vertebral fractures,"
says Fischer.
Other bones bear the brunt
of mineral loss as well. According to Fischer, the distal parts of
the long bones in the arms lose
bone mass. When people fall,
they instinctively extend their
arms to break the fall; the wrist

TITUTE OF RADIOLOGY
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:es the full impact of the
ody's weight and breaks, resultg in approximately 250,000
rist fractures annually.
'Part of a physician's evaluaon of fracture risk has to include,
in addition to bone mineral
measurements, extrinsic risk factors, such as the patient's balance
and safety risks in the home for
patients with osteoporosis. Throw
rugs, unlighted stairways, and
uneven floors must be factored
into fracture risk. Also important
to consider are the intrinsic risk
factors, like calcium and vitamin
D intake, medications that could
contribute to bone loss, and
a patient's overall nutritional
status—considerations that
make people more likely to suffer
a fracture," says Fischer.

bones with aches."
-WILLIAM SHAKESPEARE

Other uses for DEXA
DEXA devices also can image
the whole spine, measure the
height of the vertebrae, and over
time track a patient's bone density
loss and detect early vertebral fractures. "It's called high-definition,
instant vertebral assessment," says
Fischer. "By comparing sequential
images of the spine, we can determine if there has been a vertebral
fracture. Based on a recent study,
patients who have had a vertebral
fracture have a three-fold to
eleven-fold greater risk of having
another fracture." This vertebral
height measurement can be done
at the same time as conventional
bone density testing to add more

CASE STUDIES
The typical candidate for osteoporosis is a postmenopausal woman with one or more risk factors.
DEXA is utilized both to detect bone mineral loss and to
follow patients to assess the effectiveness of therapeutic
interventions. The following cases are illustrative.

Case A
A 63-year-old postmenopausal woman presents for a
follow-up examination. A spine DEXA detected osteoporosis at age 61. She was post total hysterectomy
at age 38. She was begun on therapy with
Vitamin D and bisphosphonates. Her bone
mineral density, which was 0.746 gm/cm2
at age 61, is now 0.767 gm/cm2.
Although this is an increase, it is not
considered statistically significant; ie, the
increase is within the variability of the test and
it is uncertain whether it is a real increase.
She remains in the osteoporotic range of spine bone
mineral density and needs surveillance bone mineral
measurements yearly.

Case B
A 57-year-old woman with breast cancer presents
five years after osteopenia of the spine was detected
by her initial DEXA performed when she was perimenopausal. She was started on calcium and Vitamin
D supplementation, but a follow-up study of the spine
at age 56 showed mild decrease in bone density.
Despite the initiation of bisphosphonate medical therapy, she continues to lose bone mineral density and
now measures in the osteoporotic range. She is taking Aromasin® (exemestane tablets) for treatment of
her breast cancer—a further risk factor for bone
mineral loss. Referral for more intensive monitoring
of her calcium metabolism and perhaps introduction
of a structured exercise program is warranted.
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information to the assessment
of the need for pharmacologic
intervention.
DEXA devices can be used to
measure body fat with whole-body
scans as a part of research protocols. A full-body scan measures
body composition, including percentage of body fat and lean body
mass in addition to determining
bone mineral density of all bones.
DEXA tends to be more accurate
for body-fat analysis than is bioelectrical impedance analysis (BIA)
but less accurate than is water displacement, the standard criterion
for body-composition analysis.
DEXA bone density referrals
The referring physician should
fax an order to the nuclear medicine physician or give an order to
the patient to take to the exam.
Bone density examinations at
Mallinckrodt Institute can be
scheduled by calling 314-362-7111.
Referring physicians who wish to
confer with a nuclear medicine
physician can call 314-454-7997. EH

OSTEOPOROSIS RISK FACTORS
FOR MEN AND WOMEN
Indicates need for bone density testing
• Diagnosed with insulin-dependent
diabetes, liver disease, kidney disease,
or hyperthyroidism
• Family history of osteoporosis
• Asian or white
• Advanced age
• High bone turnover, which shows up as
excessive collagen in the urine
• Past vertebral fractures or fracture from
mild trauma
• Use of certain drugs that cause bone
loss, such as some barbiturates, high-dose
thyroid replacement drugs, anticonvulsants,
or steroids
• Cigarette smoking
• Excessive alcohol use
• Poor nutrition
• Low calcium intake/vitamin D deficiency
• Inactive lifestyle

Additional risk factors for men
• Thin or small build
• Anti-testosterone drug treatment for
prostate cancer

Additional risk factors for women
•Weight under 125 pounds
•Height over 57"
• Small-boned
• Menopausal and not on hormone
replacement therapy

HELPFUL WEB SITES
• National Institutes of Health Osteoporosis and
Related Bone Disease—National Resource Center:
www.osteo.org
• National Osteoporosis Foundation:
www.nof.org
• Radiological Society of North America:
www.radiologyinfo.org/content/dexa.htm
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FYI
In this section, the names of employees who are full-time
faculty or staff or who have an appointment in the
Department of Radiology or Department of Radiation
Oncology are highlighted in boldface type.

PROMOTIONS
Carmen Dence, MS,
research scientist of
radiology, was promoted
to research associate professor of radiology, Division of
Radiological Sciences,
Department of Radiology.
Issam El Naqa, PhD,
research associate, was
promoted to research
instructor in radiation
oncology, Division of Radiation Physics, Department of
Radiation Oncology.
Jacqueline Esthappan,
PhD, instructor in radiation
oncology, was promoted to
assistant professor of radiation oncology, Division of
Radiation Physics, Department of Radiation Oncology.
Pilar Herrero, MS, research
scientist of radiology, was promoted to research associate
professor of radiology, Division of Radiological Sciences,
Department of Radiology.
Eric Klein, MS, associate
professor of radiation
oncology, was promoted
to professor of radiation
oncology, Division of
Radiation Physics, Department of Radiation Oncology.

Robert McKinstry, MD,
PhD, assistant professor
of radiology, was promoted
to associate professor
of radiology, Division of
Diagnostic Radiology,
Department of Radiology.

Eduardo Moros, PhD,
associate professor of radiation oncology, was promoted
to professor of radiation
oncology, Division of Radiation Physics, Department of
Radiation Oncology.

Suresh Vedantham, MD,
assistant professor of
radiology, was promoted
to associate professor of
radiology, Division of
Diagnostic Radiology,
Department of Radiology.

Abraham Snyder, MD,
PhD, research scientist of
radiology, was promoted to
research associate professor
of radiology, Division of
Radiological Sciences,
Department of Radiology.

Sally Wagner-Schwarz,
RPh, MS. research scientist
of radiology, was promoted
to research associate
professor of radiology,
Division of Radiological
Sciences, Department of
Radiology.

Senturia Lecture
On February 21, Robert Hattery, MD, executive director of The American Board of
Radiology, presented the Eleventh Annual Hyman R. Senturia Lecture. He spoke on
"The paradigm shift from lifetime to 10-year time-limited certificates: the ABR
Maintenance of Certification Plan."
Hattery (right) received a commemorative plaque from Gilbert lost, MD, chairman of the Department of Radiology
and director of Mallinckrodt Institute.

);

NEW FACULTY
Wilson Edwards, PhD,
research instructor in radiology, Division of Radiological
Sciences, Department of
Radiology.
Lakshmi Santanam, PhD,
instructor in radiation
oncology, Department
of Radiation Oncology.

JOINT
APPOINTMENT
Denise Head, PhD, assistant
professor of psychology, was
appointed assistant professor
of radiology, Division of
Radiological Sciences,
Department of Radiology.
Yoram Rudy, PhD, professor
of biomedical engineering,
was appointed research professor of radiology, Division
of Radiological Sciences,
Department of Radiology.

GRANTS
Jason Lewis, PhD, assistant professor of radiology,
as principal investigator,
received a one-year, $249,000
grant from the National
Institutes of Health for his
research on "Beta imager
2000Z digital imaging system."

LOG
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Wen Ping Li, PhD, research
instructor of radiology, as
principal investigator,
received a Molecular Imaging
Center Pilot Research Project
grant of $20,000 for research
on "PET imaging of pancreatic cancer via EGF receptor."
Buck Rogers, PhD, assistant professor of radiation
oncology and of radiology,
received a $1.2 million grant
from the National Institutes
of Health for work on
"Somatostatin receptor
based PET imaging of gene
transfer." Coinvestigators
for the four-year grant are
Nobuo Horikoshi, PhD,
assistant professor of radiation oncology, and Gregory
Adams, PhD, Fox Chase
Cancer Center. Collaborators for the project include
Carolyn Anderson, PhD,
associate professor of radiology; David Piwnica-Worms,
MD, PhD, professor of radiology, and Michael Welch,
PhD, professor of radiology.
Sheng-Kwei Song, PhD,
assistant professor of radiology, as principal investigator,
received a $925,000 grant
from the National Institutes
of Health/National Institute
of Neurological Disorders
and Stroke for research on

"Evaluation of spinal cord
white matter injury using
DTI." Coinvestigators for the
four-year grant are Anne
Cross, MD, Department of
Neurology; John Russell,
PhD, Department of Molecular
Biology and Pharmacology;
Philip Bayly, PhD, Department
of Mechanical Engineering
and Aerospace; and Robert
Schmidt, MD, PhD, Department of Pathology and
Immunology.

APPOINTMENTS/
ELECTIONS

Jie Zheng, PhD, assistant
professor of radiology, as
principal investigator,
received a $1.5 million grant
from the National Institutes
of Health/National Heart,
Lung, and Blood Institute for
work on "Quantification of
regional myocardial oxygenation by MRI." Coinvestigators
for the four-year grant are
Robert Gropler, MD, professor of radiology; Joseph
Deasy, PhD, associate professor of radiation oncology;
and Pamela Woodard, MD,
assistant professor of
radiology; and Michael
Jerosch-Herold, PhD,
Oregon Health and Science
University, Portland.

Jeffrey Bradley, MD, assistant professor of radiation
oncology, was elected to a
three-year term as memberat-large of the Executive
Committee of the American
College of Radiology's
(ACR's) Radiation Therapy
Oncology Group. He also
was elected as a member of
the ACR's Lung Cancer
Expert Panel (appropriateness criteria).

Samuel Achilefu, PhD,
associate professor of radiology, was appointed to a
three-year term as a member
of the Microscopic Imaging
Study Section, Center for
Scientific Review, United
States Department of Health
and Human Services,
National Institutes of Health.

Craig Glaiberman, MD,
instructor in radiology, was
appointed to the Professional Education Committee
of the Society of Interventional Radiology.
Sean Higginson, MD,
third-year diagnostic radiology resident, is the first
resident physician to be
appointed to the Board of
Directors for RADPAC, the
political action committee
of the American College of
Radiology Association.
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Continued from page 21
Eric Klein, MS, professor
of radiation oncology, was
appointed as chair of the
American Association
of Physicists in Medicine
Subcommittee on
Quality Assurance for
Radiation Therapy.
Jason Lewis, PhD, assistant professor of radiology,
was elected to a two-year
term as treasurer of the
Radiopharmaceutical Science
Council of The Society of
Nuclear Medicine.
Robert McKinstry, MD,
PhD, associate professor of
radiology, was appointed to
the Trans-National Institutes
of Health Panel on Incidental
Findings: Detection and Disclosure of Incidental Findings
in Neuroimaging Research.
He was appointed to the
External Advisory Committee
of the Comprehensive Sickle
Cell Center, St. Jude Children's Research Hospital,
Memphis, Tennessee.
JeffMichalski, MD,
associate professor of
radiation oncology, was
appointed to the Board of
Directors of the Missouri
Radiological Society.
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Pamela Woodard, MD,
assistant professor of
radiology, was appointed
to a three-year term on the
Scientific Program Committee of the American Heart
Association and as chair of
the association's Program
Committee for the Cardiovascular Radiology and
Intervention Council.

HONORS/AWARDS
Louis Gilula, MD, professor
of radiology and of surgery,
received the 2005 Outstanding Presentation Award
for "Complications of
fluoroscopically guided
extraforaminal cervical nerve
blocks: an analysis of 1,036
injections" at the 37Ul Annual
Diagnostic Course in Davos
Musculoskeletal Diseases,
Davos, Switzerland, April 28. As visiting professor, he
was a member of the Board
Review on Musculoskeletal
Radiology, Oregon Health
and Science University, Portland, April 22-25.

LECTURES
Carolyn Anderson, PhD,
associate professor of radiology, presented "Chemistry,
imaging and therapy
application of copper-64
radiopharmaceuticals" to
the Department of Chemistry,
Florida State University, Tallahassee, February 24. She
spoke on "Molecular imaging
of cancer with copper-64
radiopharmaceuticals" at
Florida Atlantic University,
Boca Raton, March 25.

Jeffrey Brown, MD, professor of radiology, presented
"MR contrast agents" at Vanderbilt University, Nashville,
Tennessee, February 15. He
spoke on "MR imaging of the
indeterminate renal mass"
at Radiology Grand Rounds:
MRI of Cholangiocarcinoma
and Gallbladder Cancer,
Wake Forest University,
Winston-Salem, North
Carolina, March 16.
Colin Derdeyn, MD, associate professor of radiology
and of neurology and neurological surgery, presented
"Subarachnoid hemorrhage:
clip versus coil" and "Neurointerventional procedures
for the practicing intensivist"
at the 34u' Critical Care
Congress, Society of Critical
Care Medicine, Phoenix,
Arizona, January 17. He spoke
on "Overview of cerebral
hemodynamics" at the 5th
Annual International Meeting
on Cerebral Revascularization,
St. Louis, Missouri, January
20. He spoke on "Ongoing
carotid stent trials" and
"Selection of patients for
cerebral revascularization:
the role of hemodynamic
assessment" at the 8"' Annual
Joint Meeting of the American
Association of Neurological
Surgeons/Congress of
Neurological Surgeons Joint
Section on Cerebrovascular
Disease and American Society of fnterventional and
Therapeutic Neuroradiology,
New Orleans, Louisiana,

February 3 and 4. Derdeyn
presented "Thrombolytic
therapy for acute stroke"
at the 3011' Annual International Stroke Conference,
New Orleans, Louisiana,
February 4. He spoke on
"Clip versus coil for aneurysm
debate: pro coils" at the
NeuroCritical Care Society
Annual Meeting, Phoenix,
Arizona, February 25.
Louis Gilula, MD, professor
of radiology and of surgery,
spoke on "Complications in
1036 cervical nerve blocks"
at the American Society of
Spine Radiology 2005 Annual
Symposium, San Juan,
Puerto Rico, February 27.
He presented "Wrist imaging
entities to know that often
are not" at Balgrist Hospital,
Zurich, Switzerland, March
5. He presented "Wrist and
hand" at the 37th Annual
Diagnostic Course in Davos
Musculoskeletal Diseases,
Davos, Switzerland, April 2-8.
Perry Grigsby, MD, profes
sor of radiation oncology
and of radiology, spoke on
"Radiation therapy for thyroid
cancer" at the Greater St. Lords
Society of Radiologists meet
ing, St. Louis, Missouri,
February 15. He presented
"Adjuvant treatment of thyroi< I
cancer" at the 13lh Annual
Refresher Course and
Update in General Surgery,
Washington University in
St. Louis, Missouri,
February 24.

MALLINCKRODT INSTITUTE OFRADIOLOC i

Jay Heiken, MD, professor
jf radiology, spoke on "CT
evaluation of small bowel
jbstruction" and "CT of the
abdominal aorta: aneurysm
rupture and post-operative
complications" at Indiana
University, Indianapolis,
January 12. He presented
"Contrast administration and
scan timing for MDCT: single
to 4, 8, and 16 row" and
"CT evaluation of suspected
abdominal aortic rupture"
at Practical Radiology at
Whistler, sponsored by the
University of British Columbia,
Whistler, February 6-11. He
presented "Scan and contrast
administration principles of
MDCT" at the MDCT Imaging:
New Challenges for Scan
and Contrast Optimization
Symposium, European
Congress of Radiology,
Vienna, Austria, March 4-8.
He spoke on "Contrast
administration and scan
timing for multidetector
CT," "CT evaluation of small
bowel obstruction," and
"Tough liver cases: take the
challenge!" at the Intemaional London Course in CT,
V1RI, and PET, Auchterarder,
Perthshire, Scotland, March
20-24. He presented "Contrast optimization in MDCT,"
"Liver imaging with MDCT,"
and "Pancreatic MDCT" at
MDCT: A Practical Approach,
sponsored by the Society of
Computed Body Tomography and Magnetic Resonance,
Scottsdale, Arizona, April 2,
and Dallas, Texas, April 16.
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Richard Laforest, PhD,
assistant professor of radiology, spoke on "Measurements
of input functions in rodents:
challenges and solutions" at
the Third La Jolla Conference:
The Magic Bullet, a Century
Later, La Jolla, California,
February 26.

William McAlister, MD,
professor of radiology,
presented a workshop on
"Skeletal dysplasia" at the 48d'
Annual Meeting of the Society
for Pediatric Radiology, New
Orleans, Louisiana, May 5.

Jeff Michalski, MD, associate professor of radiation
oncology, spoke on "The role
of external RT, brachytherapy,
adjuvant/neoadjuvant hormonal therapy for localized
disease and following RP" at
the Israel Society for Clinical

Biello Lecture
Daniel Silverman, MD, PhD, associate professor of molecular and medical pharmacology, is head of the neuronuclear section and associate director of the Alzheimer's Disease Center Imaging Core at the David Geffen School of Medicine at the University of
California, Los Angeles. As guest speaker for the Nineteenth Annual Daniel R. Biello
Memorial Lecture on March 14, Silverman spoke on "FDG-PET in the evaluation of mild
cognitive impairment, Alzheimer's disease, and related disorders."
Shown with Silverman (left) is Barry Siegel, MD, chief of the Institute's Division of Nuclear Medicine and coordinator of
the Biello Lecture.
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Oncology and Radiation
Therapy Conference, Eilat,
Israel, January 12-14. He
presented "Radiation therapy
for prostate cancer, from 3D
CRT to IMRT" at the 15"'
Annual Meeting of the
American College of Radiation Oncology, Las Vegas,
Nevada, February 24-27.
Jeffrey Neil, MD, PhD,
professor of neurology, of
pediatrics, and of radiology,
presented "Survey and
current status of research
on biophysical issues in
diffusion MRI of brain.
Progress since the last
workshop in St. Malo" at the
International Society for MR
in Medicine Workshop on
Methods for Quantitative
Diffusion MRI of the Human
Brain, Lake Louise, Alberta,
Canada, March 13-16.
Fred Prior, PhD, research
associate professor of
radiology, spoke on "Digital
modalities, study acquisition,
distribution and storage
requirements" and "Storage
hardware and infrastructure"
at the PACS 2005 Conference, San Antonio, Texas,
March 9-12.
David Rubin, MD, associate
professor of radiology,
spoke on "Knee" at the 37th
Annual Diagnostic Course
in Davos Musculoskeletal
Diseases, Davos, Switzerland,
April 2-8.

Barry Siegel, MD, professor
of radiology and of medicine,
presented "Breast cancer:
solutions" and "Gynecological malignancies: solutions"
at the PET/CT and SPECT/CT
Imaging of Cancer for
Radiologists and Nuclear
Physicians, sponsored by
Johns Hopkins University,
Baltimore, Maryland, March
18 and 19. He spoke on "PET
and PET/CT in lung cancer"
and "PET in gynecologic
cancer" at Imaging 2005: Hot
Topics and Current Issues,
sponsored by The New York
Roentgen Society, New York
City, New York, March 30April 2. He presented "PET
and PET/CT in lung cancer
and breast cancer" at Radiology Grand Rounds as well as
"PET artifacts and variants"
and "Endocrine nuclear
medicine imaging" at Eastern
Virginia Medical School,
Norfolk, Virginia, April 18.
Siegel presented "Applications of PET and PET/CT in
clinical oncology" at Nuclear
Medicine Grand Rounds,
State University of New York
at Buffalo, April 27.
Marilyn Siegel, MD,
professor of radiology and of
pediatrics, spoke on "CT/MRI
of focal hepatic masses in
children" and "CT of common
thoracic lesions in children"
at Oregon Health and
Science University, Portland,
February 3. She presented
"Pediatric CT angiography,"
"CT angiography of adult
mediastinal arterial anomalies," and "CT angiography
of adult mediastinal venous
anomalies" at the Advanced

Topics in CT Scanning: CT
Angiography, 3D Imaging,
Virtual Imaging Course,
sponsored by Johns Hopkins
University, Los Angeles,
California, April 1-3 and Baltimore, Maryland, April 7-9.
She spoke on "MDCT of
adult mediastinal vascular
anomalies," "CT/MR of pediatric mediastinal lesions,"
and "CT of pediatric congenital lung anomalies" at North
Shore University Hospital,
Manhasset, New York, April 13.
Joseph Simpson, MD,
PhD, professor of radiation
oncology, presented "Image
guided radiation therapy"
at the Carle Clinic, Urbana,
Illinois, January 29.
Franz Wippold, MD, professor of radiology, spoke on
"Lumbar spine: the herniated
disk" at the 2005 Annual Meeting of the American Academy
of Orthopaedic Surgeons,
Washington, DC, February 24.

SYMPOSIA
In this section ofFYI, only
those faculty and staff
who have Department of
Radiology or Department
of Radiation Oncology
appointments are listed.

THE SOCIETY OF
GASTROINTESTINAL
RADIOLOGISTS/
THE SOCIETY OF
URORADIOLOGY
Abdominal Radiology
Course 2005
San Antonio, Texas
February 27-March 4, 2005
Dennis Balfe, MD, program
director.
Jay Heiken, MD, moderator,
Plenary Session: Abdominal
Emergencies.
Christine Menias, MD,
panelist, Unknown Case.
WORKSHOPS
Jay Heiken, MD, "Small
bowel obstruction."
Elizabeth McFarland, MD,
"CT colonography: technique
and avoiding pitfalls."
Christine Menias, MD,
"CTofRLQpain."
PLENARY SESSION
Sharlene Teefey, MD,

"Complicated cholecystitis."
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AMERICAN COLLEGE OF
CARDIOLOGY
54th Annual Scientific
Session Exposition
Orlando, Florida
March 6-9, 2005
Robert Gropler, MD,
cochair, Advances in
SPECT/PET for Risk
Stratification; moderator,
Read with the Experts...
Imaging Perfusion and
Metabolism with PET,
SPECT, and PET/CT.
Madelyn Stazzone, MD;
Pamela Woodard, MD;
Michael Pasque, MD;
Glenn Foster, RT; Philip
Ludbrook, MD, "Myocardial
scarring and fibrosis in the
failing single ventricle after
Fontan operation: a new
insight by MRI studies."

SOCIETY OF COMPUTED
BODY TOMOGRAPHY AND
MAGNETIC RESONANCE
28th Annual Course
South Beach, Florida
March 21-25, 2005
REFRESHER COURSE
Marilyn Siegel, MD, "Mediastinal masses and congenital
lung lesions in children."

FOCUS SESSIONS
Kyongtae Bae, MD, PhD,
"Principles and practice of
contrast material delivery for
MDCT'and "PET/CT basic
principles."
Stuart Sagel, MD, "CT of
thoracic vascular masses."

CARDIOVASCULAR IMAGING
SESSION 2
Marilyn Siegel, MD,
"MDCT of adult congenital
heart disease"
SPOTLIGHT ON PROTOCOLS:
PERIPHERAL MRA
Stuart Sagel, MD, "CT

angiography for pulmonary
embolism: technique
interpretation and role."

Purdy Lecture
The Department of Radiation Oncology sponsored the Third Annual James A.
Purdy Physics Lecture on April 22. Clifton Ling, PhD, chairman of the Department
of Medical Physics at Memorial Sloan-Kettering Cancer Center, presented the
keynote address: "p02 - C135 - D3 and back."
(Left to right): Simon Powell, MD, PhD, chairman of the Department of Radiation Ontology; Ling; and James Purdy, PhD.

Victor Davila-Roman, MD,
"Cardiac resynchronization
therapy improves left ventricular diastolic function in
nonischemic heart failure."

FOCAL SPOT, SPRING 2005

25

• :

FYI
SYMPOSIA
Continued from page 25

SOCIETY OF
INTERVENTION
RADIOLOGY
30th Annual
Scientific Meeting
New Orleans, Louisiana
March 31-April 5, 2005
Daniel Brown, MD, panelist, Lessons Learned: Chest
Interventions; comoderator,
Visceral Arteries/Solid Organ
Intervention; coordinator,
Gastrointestinal IR: Techniques and Management.
Michael Darcy, MD, panelist, Case Based Review:
Vascular Interventions II;
comoderator, Portal
Hypertension.
David Hovsepian, MD,
comoderator, Fibroid
Embolization.

Thomas Vesely, MD, coordinator, Venous Access.
WORKSHOPS
Daniel Brown, MD,
"Regional cancer therapy,"
"The IR approach."
Craig Glaiberman, MD,
"Venous access," "Gastrointestinal interventions."
Suresh Vedantham, MD,
"Thrombolytic therapy for
venous disease."
Thomas Vesely, MD,
"Hemodialysis access."
PLENARY SESSIONS
Daniel Brown, MD, "What
the IR needs to know—HCC."
Michael Darcy, MD,
"Ambulatory phlebectomy:
indications and techniques."
Colin Derdeyn, MD,
"Stroke management: acute
stroke imaging."

Thomas Vesely, MD,
"Angioplasty: POBA and
beyond."
SCIENTIFIC PRESENTATIONS
David Hovsepian, MD,
"Comparison of adjunctive
use of rofecoxib (Vioxx)
vs. ibuprofen in the management of postoperative pain
after UFE."

Petr Novak, PhD, recipient,
Young Investigator Travel
Award; comoderator,
Engineering/Physics
Symposium: Image Guided
Thermal Therapy, Treatment
Monitoring, and Tissue
Assessment.
Joseph Roti Roti, PhD, member, Organizing Committee.

Suresh Vedantham, MD;
Gregorio Sicard, MD;
Brian Rubin, MD; Thomas
Pilgram, PhD; Thomas
Vesely, MD; Michael
Darcy, MD, "Uiofemoral
DVT: pharmacomechanical
thrombolysis with early
stenting versus conventional
pharmacologic thrombolysis."

William Straube, MS,
comoderator, Engineering/
Physics Symposium: Treatment Planning, Control, and
Thermal Modeling.

Thomas Vesely, MD, "Measurement of air flow through
a valved peelable introducer
sheath," "Use of stent grafts
to repair hemodialysis graft
related pseudoaneurysms."

SCIENTIFIC PRESENTATIONS
Bibianna Cha; Eduardo
Moros, PhD; William
Straube, MS; Robert
Myerson, MD, PhD; Petr
Novak, PhD, "Final design
and preliminary testing of a
Linac-SURLAS-patient transport for simultaneous thermoradiotherapy."

SOCIETY FOR THERMAL
MEDICINE
2005 Annual Meeting
Bethesda, Maryland
April 1-3, 2005

PLENARY SESSIONS
Eduardo Moros, PhD,
"SURLAS," "Highlights of
engineering/physics."

Eduardo Moros, PhD,
comoderator,Engineering/
Physics Workshop.

I
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Eduardo Moros, PhD;
James Alaly; Konstantin
Zakaryan, PhD; Joseph
Deasy, PhD; Petr Novak,
i PhD, "Integrated thermoradioi therapy treatment planning
i system—a computational
I environment for long-term
i developments and initial
results."
Eduardo Moros, PhD,
"Basic bio-heat transfer
considerations and effective
heating of tumors in
animal models."
Robert Myerson, MD,
PhD, "Simultaneous radiation therapy and hyperthermia
in the elective treatment of
subclinical disease in high
risk breast carcinoima: a
phase III comparison of post
treatment normal tissue
effects in heated and
unheated portions of the
chest wall."

Petr Novak, PhD; Eduardo
Moros, PhD; William
Straube, MS, "The impact
of ultrasound nonlinear
propagation on SURLAS
design and performance."
Joseph Roti Roti, PhD,
"Changes in nuclear DNA
organization and DNA repair
proteins that lead to
radiosensitization by 41CC
hyperthermia."
William Straube, MS,
"An in vivo system for the
determination of the effect
of temperature on
backscattered ultrasound."
Robert VanderWaal, PhD,
"Heat induced 'masking' of
protein disulfide isomerase,
a redox sensitive nuclear
component of the DNAnuclear matrix anchoring
complex."
Mai Xu, MD, PhD,
"Enhancement of thermal
radiosensitization by
Indomethacin and related
compounds."

Konstantin Zakaryan,
PhD; James Alaly; Petr
Novak, PhD; Joseph Deasy,
PhD; Eduardo Moros, PhD,
"Simple acoustic beam model
for thermoradiotherapy
implemented in an open
source treatment planning
research system."

AMERICAN RADIUM
SOCIETY
87th Annual Meeting
Barcelona, Spain
April 30-May 4, 2005
Perry Grigsby, MD, "Functional imaging, translational
science, and clinical outcome
in carcinoma of the cervix";
"Advances in GYN malignancies"; "Assessing tumor
hypoxia in cervical cancer
by positron emission tomography with ^Cu-ATSM";
"Pre-treatment metabolic
activity in cervical cancer."

Parag Parikh, MD,
"Inspiration gating reduces
lung cancer treatment volumes
and potential irradiation
treatment toxicities," "The
use of radiation in the treatment of Hodgkin's disease."

In the Winter 2004/2005
issue of Focal Spot
magazine, Barry Brunsden
was inadvertently omitted from the list of
Hobbit research team
members (page 19).
We regret the error.
As a research engineer,
Brunsden is an important part of the Hobbit
team as well as other
research conducted in
the Institute's Electronic
Radiology Laboratory.

Lilie Lin, MD, "Sequential
FDG-PET brachytherapy
treatment planning in carcinoma of the cervix."

We sadly report the death of John Christian Mason, PhD, who died suddenly on April 24.
He was 34 years old. Dr. Mason joined the Division of Radiological Sciences in October 2004
as a postdoctoral research associate in the Institute's Optical Radiology Laboratory. He is
survived by his wife, Hyeran, and four-year-old daughter Brooke. Donations may be made
to the Mason Family Trust, Pulasld Bank, 12300 Olive Boulevard, St. Louis, Missouri 63141.
Send to the attention of Chuck Carpenter, senior vice president.
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ALUMNI NEWS
Ronald Evens, MD, former
chairman of the Department
of Radiology and director of
Mallinckrodt Institute of
Radiology (1971-1999),
retired May 1, 2005, as president of Barnes-Jewish Hospital in St. Louis. He maintains
a senior-level role with BJC
HealthCareSM, where he will
lend his experience and
expertise on special projects.
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Gary Shackelford, MD,
emeritus professor of
radiology, retired from
Mallinckrodt Institute in
June 2002. But the Shackelf ords (wife Penny was a
physician in the Department of Pediatrics) are
working harder than ever
to restore their rural property in southern Wisconsin
(Fair Meadows) to its natural condition of woods,
prairies, and wetlands.
They are the recipients of
three state and federal
grants to assist in their
restoration efforts.
In 2001, Fair Meadows
was named Wisconsin's
Outstanding Tree Farm by
the American Tree Farm
System and, in 2003, the
Shackelfords received the
Natural Roadside Award
from the Rock County
Conservationists, a local
group that promotes conservation. They also have
been the recipients of a
Wildlife Conservation
Award from the Rock
County Land Conservation
Department.

(left to right) Drs. Gary and Penny Shackelford and Beverlee Sagel.
Photo courtesy of Stuart Sogel, MD, professor of radiology.
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RISK OF COLON CANCER?
SCREENING COLONOSCOPY
50 YEARS

^>olorectal cancer is the
second most common
cause of cancer-related
deaths in the United
States. Ifcolorectal
cancer is diagnosed *y
in its early stages,
the survival rate /*
is 90%.

/I

Help fight colon
cancer by volunteering for the
National Colon
Cancer Screening at
Mallinckrodt Institute of
Radiology at Washington
University in St. Louis.
This study is part of a National
Cancer Institute-funded effort to determine whether computed tomography (CT)
colonography can provide the necessary information for doctors to diagnose colon
cancer in its early stages.

k

CT colonography, also called virtual colonoscopy, is faster (takes about 20 minutes)
and less invasive than standard colonoscopy. Eligible study participants will receive a
CT colonography (free of charge) in addition to your regularly scheduled colonoscopy
(billed to your insurance carrier or to you).
Christine Menias, MD, a board-certified radiologist, is the principal investigator
of the Washington University segment of the study. For more information, call
Ruth Holdener, RT, at (314) 747-2034.
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